Caleb Houstan
SG - ORL
Height: 6-8
Weight: 205 lbs
Age: 21
College: Michigan
2024 Game Logs
DATE |
TM |
OPP |
MIN |
FGA |
FGM |
FG% |
3PA |
3PM |
3P% |
FTA |
FTM |
FT% |
REB |
AST |
STL |
BLK |
TO |
FOUL |
PTS |
FPTS |
Apr 12 |
ORL |
@ PHI |
0 |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Apr 10 |
ORL |
@ MIL |
11 |
5 |
0 |
0% |
5 |
0 |
0% |
0 |
0 |
0% |
2 |
1 |
0 |
0 |
0 |
0 |
0 |
4 |
Apr 9 |
ORL |
@ HOU |
7 |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
2 |
Apr 7 |
ORL |
CHI |
0 |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Apr 5 |
ORL |
@ CHA |
0 |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Apr 3 |
ORL |
@ NO |
0 |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Apr 1 |
ORL |
POR |
0 |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Mar 30 |
ORL |
MEM |
20 |
4 |
3 |
75% |
4 |
3 |
75% |
0 |
0 |
0% |
1 |
0 |
0 |
0 |
0 |
2 |
9 |
10 |
Mar 29 |
ORL |
LAC |
14 |
4 |
3 |
75% |
3 |
2 |
67% |
0 |
0 |
0% |
1 |
1 |
0 |
0 |
0 |
1 |
8 |
11 |
Mar 27 |
ORL |
GS |
0 |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Mar 23 |
ORL |
SAC |
11 |
5 |
2 |
40% |
5 |
2 |
40% |
0 |
0 |
0% |
2 |
0 |
1 |
0 |
0 |
0 |
6 |
10 |
Mar 21 |
ORL |
NO |
13 |
3 |
1 |
33% |
3 |
1 |
33% |
0 |
0 |
0% |
1 |
0 |
0 |
0 |
1 |
1 |
3 |
3 |
Mar 19 |
ORL |
CHA |
14 |
5 |
1 |
20% |
5 |
1 |
20% |
0 |
0 |
0% |
1 |
0 |
0 |
0 |
0 |
1 |
3 |
4 |
Mar 17 |
ORL |
TOR |
15 |
4 |
1 |
25% |
4 |
1 |
25% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
1 |
3 |
3 |
Mar 15 |
ORL |
@ TOR |
2 |
1 |
0 |
0% |
1 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Mar 13 |
ORL |
BKN |
1 |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Mar 10 |
ORL |
IND |
22 |
2 |
0 |
0% |
1 |
0 |
0% |
0 |
0 |
0% |
2 |
1 |
0 |
0 |
0 |
3 |
0 |
4 |
Mar 8 |
ORL |
@ NY |
4 |
1 |
0 |
0% |
1 |
0 |
0% |
2 |
2 |
100% |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
2 |
Mar 6 |
ORL |
@ WAS |
4 |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Mar 5 |
ORL |
@ CHA |
0 |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Mar 3 |
ORL |
DET |
3 |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0% |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Feb 29 |
ORL |
UTA |
13 |
4 |
1 |
25% |
4 |
1 |
25% |
0 |
0 |
0% |
2 |
1 |
0 |
2 |
0 |
3 |
3 |
11 |
Feb 27 |
ORL |
BKN |
30 |
4 |
3 |
75% |
4 |
3 |
75% |
0 |
0 |
0% |
6 |
1 |
2 |
0 |
1 |
3 |
9 |
21 |
Feb 25 |
ORL |
@ ATL |
20 |
9 |
4 |
44% |
9 |
4 |
44% |
0 |
0 |
0% |
2 |
0 |
0 |
0 |
0 |
1 |
12 |
14 |
Feb 24 |
ORL |
@ DET |
0 |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Feb 22 |
ORL |
@ CLE |
0 |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Feb 14 |
ORL |
NY |
25 |
3 |
2 |
67% |
2 |
2 |
100% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
1 |
1 |
6 |
5 |
Feb 13 |
ORL |
OKC |
2 |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0% |
1 |
1 |
0 |
0 |
0 |
0 |
0 |
3 |
Feb 10 |
ORL |
CHI |
0 |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Feb 8 |
ORL |
SA |
2 |
1 |
1 |
100% |
1 |
1 |
100% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
3 |
Feb 6 |
ORL |
@ MIA |
3 |
1 |
0 |
0% |
1 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Feb 4 |
ORL |
@ DET |
0 |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Feb 2 |
ORL |
@ MIN |
0 |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Jan 31 |
ORL |
@ SA |
0 |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Jan 29 |
ORL |
@ DAL |
0 |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Jan 28 |
ORL |
PHO |
1 |
1 |
1 |
100% |
1 |
1 |
100% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
3 |
Jan 26 |
ORL |
@ MEM |
0 |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Jan 22 |
ORL |
CLE |
23 |
3 |
2 |
67% |
3 |
2 |
67% |
0 |
0 |
0% |
2 |
0 |
0 |
0 |
1 |
2 |
6 |
7 |
Jan 21 |
ORL |
MIA |
8 |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
2 |
Jan 19 |
ORL |
PHI |
15 |
3 |
0 |
0% |
2 |
0 |
0% |
0 |
0 |
0% |
2 |
0 |
0 |
0 |
1 |
0 |
0 |
1 |
Jan 17 |
ORL |
@ ATL |
13 |
7 |
1 |
14% |
7 |
1 |
14% |
1 |
0 |
0% |
1 |
0 |
1 |
0 |
0 |
3 |
3 |
6 |
Jan 15 |
ORL |
@ NY |
21 |
7 |
1 |
14% |
7 |
1 |
14% |
5 |
4 |
80% |
1 |
0 |
0 |
0 |
0 |
4 |
7 |
8 |
Jan 13 |
ORL |
@ OKC |
34 |
13 |
5 |
38% |
12 |
4 |
33% |
0 |
0 |
0% |
3 |
2 |
1 |
0 |
3 |
0 |
14 |
20 |
Jan 12 |
ORL |
@ MIA |
31 |
9 |
3 |
33% |
9 |
3 |
33% |
0 |
0 |
0% |
2 |
3 |
0 |
0 |
0 |
4 |
9 |
16 |
Jan 9 |
ORL |
MIN |
34 |
12 |
3 |
25% |
10 |
2 |
20% |
0 |
0 |
0% |
7 |
2 |
0 |
0 |
0 |
2 |
8 |
19 |
Jan 7 |
ORL |
ATL |
36 |
15 |
8 |
53% |
14 |
7 |
50% |
3 |
2 |
67% |
2 |
4 |
1 |
0 |
0 |
2 |
25 |
35 |
Jan 5 |
ORL |
@ DEN |
24 |
6 |
3 |
50% |
5 |
2 |
40% |
2 |
0 |
0% |
0 |
1 |
0 |
0 |
0 |
3 |
8 |
10 |
Jan 3 |
ORL |
@ SAC |
30 |
6 |
4 |
67% |
6 |
4 |
67% |
3 |
3 |
100% |
2 |
1 |
4 |
0 |
1 |
2 |
15 |
26 |
Jan 2 |
ORL |
@ GS |
8 |
3 |
2 |
67% |
3 |
2 |
67% |
0 |
0 |
0% |
1 |
0 |
0 |
0 |
0 |
1 |
6 |
7 |
Dec 31 |
ORL |
@ PHO |
7 |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Dec 29 |
ORL |
NY |
20 |
5 |
0 |
0% |
5 |
0 |
0% |
0 |
0 |
0% |
2 |
0 |
0 |
0 |
1 |
1 |
0 |
1 |
Dec 27 |
ORL |
PHI |
25 |
4 |
2 |
50% |
4 |
2 |
50% |
1 |
1 |
100% |
6 |
2 |
0 |
0 |
2 |
2 |
7 |
15 |
Dec 26 |
ORL |
@ WAS |
11 |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0% |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Dec 23 |
ORL |
@ IND |
20 |
4 |
2 |
50% |
4 |
2 |
50% |
0 |
0 |
0% |
3 |
0 |
1 |
0 |
1 |
3 |
6 |
11 |
Dec 21 |
ORL |
@ MIL |
18 |
3 |
0 |
0% |
3 |
0 |
0% |
0 |
0 |
0% |
1 |
0 |
0 |
1 |
0 |
2 |
0 |
3 |
Dec 20 |
ORL |
MIA |
14 |
10 |
3 |
30% |
10 |
3 |
30% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
0 |
9 |
9 |
Dec 17 |
ORL |
@ BOS |
15 |
4 |
2 |
50% |
3 |
1 |
33% |
3 |
3 |
100% |
3 |
0 |
0 |
0 |
0 |
2 |
8 |
12 |
Dec 15 |
ORL |
@ BOS |
10 |
5 |
2 |
40% |
4 |
1 |
25% |
0 |
0 |
0% |
2 |
1 |
0 |
0 |
0 |
0 |
5 |
9 |
Dec 11 |
ORL |
CLE |
0 |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Dec 8 |
ORL |
DET |
25 |
6 |
2 |
33% |
6 |
2 |
33% |
0 |
0 |
0% |
4 |
1 |
0 |
0 |
0 |
1 |
6 |
12 |
Dec 6 |
ORL |
@ CLE |
10 |
2 |
0 |
0% |
1 |
0 |
0% |
0 |
0 |
0% |
3 |
0 |
0 |
0 |
0 |
1 |
0 |
4 |
Dec 2 |
ORL |
@ BKN |
16 |
3 |
1 |
33% |
3 |
1 |
33% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
1 |
3 |
3 |
Dec 1 |
ORL |
WAS |
0 |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Nov 29 |
ORL |
WAS |
10 |
3 |
3 |
100% |
3 |
3 |
100% |
0 |
0 |
0% |
3 |
1 |
0 |
0 |
1 |
3 |
9 |
13 |
Nov 26 |
ORL |
CHA |
12 |
2 |
1 |
50% |
2 |
1 |
50% |
3 |
3 |
100% |
2 |
0 |
0 |
0 |
0 |
2 |
6 |
8 |
Nov 24 |
ORL |
BOS |
8 |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0% |
2 |
0 |
1 |
0 |
0 |
0 |
0 |
4 |
Nov 22 |
ORL |
DEN |
0 |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Nov 21 |
ORL |
TOR |
3 |
1 |
0 |
0% |
1 |
0 |
0% |
0 |
0 |
0% |
1 |
1 |
1 |
0 |
0 |
0 |
0 |
5 |
Nov 19 |
ORL |
@ IND |
8 |
1 |
0 |
0% |
1 |
0 |
0% |
0 |
0 |
0% |
0 |
2 |
0 |
0 |
2 |
1 |
0 |
1 |
Nov 17 |
ORL |
@ CHI |
6 |
1 |
1 |
100% |
1 |
1 |
100% |
0 |
0 |
0% |
2 |
0 |
0 |
0 |
0 |
0 |
3 |
5 |
Nov 15 |
ORL |
@ CHI |
0 |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Nov 14 |
ORL |
@ BKN |
4 |
1 |
1 |
100% |
1 |
1 |
100% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
1 |
3 |
3 |
Nov 11 |
ORL |
MIL |
0 |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Nov 9 |
ORL |
ATL |
0 |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Nov 6 |
ORL |
DAL |
13 |
2 |
1 |
50% |
2 |
1 |
50% |
0 |
0 |
0% |
1 |
0 |
0 |
0 |
0 |
1 |
3 |
4 |
Nov 4 |
ORL |
LAL |
3 |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0% |
1 |
1 |
0 |
0 |
0 |
0 |
0 |
3 |
Nov 2 |
ORL |
@ UTA |
0 |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Oct 31 |
ORL |
@ LAC |
3 |
5 |
2 |
40% |
4 |
1 |
25% |
1 |
1 |
100% |
0 |
0 |
0 |
0 |
0 |
0 |
6 |
6 |
Oct 30 |
ORL |
@ LAL |
0 |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Oct 27 |
ORL |
@ POR |
0 |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Oct 25 |
ORL |
HOU |
4 |
2 |
1 |
50% |
2 |
1 |
50% |
0 |
0 |
0% |
1 |
0 |
0 |
0 |
0 |
0 |
3 |
4 |